Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2005-12-12
pubmed:abstractText
The reticulocyte-type 15-lipoxygenase-1 (ALOX15) has antiinflammatory and inflammatory effects, and is implicated in the development of asthma, arthritis, and atherosclerosis. We screened the human ALOX15 gene for variations because genetic variability in ALOX15 may influence these diseases. We detected 11 variations, including five polymorphisms located in the ALOX15 promoter region. One of these polymorphisms, a C-to-T substitution at position c.-292, created a novel transcription factor binding site for SPI1. Transcription assays revealed that promoter variants with c.-292 T transcribe twice as efficiently as all the other promoter variants containing c.-292C. This was true in macrophages that constitutively express SPI1, but not in a lung epithelial cell line that does not express SPI1. Mutation of the core-binding site for SPI1 abolished the higher transcriptional activity, and electrophoretic mobility shift assays showed that SPI1 selectively binds to the mutant c.-292 T [corrected] promoter. These results were corroborated in primary human macrophages, in which macrophages from heterozygous c.-292CT carriers expressed three times more ALOX15 mRNA than macrophages from homozygous c.-292CC carriers. We conclude that the c.-292 T allele in the ALOX15 promoter generates a novel binding site for the transcription factor SPI1 that results in higher transcription of the gene in macrophages. This may lead to an increase in ALOX15-mediated lipid metabolites, which play a role in inflammation.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1098-1004
pubmed:author
pubmed:copyrightInfo
2005 Wiley-Liss, Inc.
pubmed:issnType
Electronic
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
78-87
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:16320347-Alleles, pubmed-meshheading:16320347-Animals, pubmed-meshheading:16320347-Arachidonate 15-Lipoxygenase, pubmed-meshheading:16320347-Binding Sites, pubmed-meshheading:16320347-Cells, Cultured, pubmed-meshheading:16320347-Genetic Variation, pubmed-meshheading:16320347-Haplotypes, pubmed-meshheading:16320347-Heterozygote, pubmed-meshheading:16320347-Humans, pubmed-meshheading:16320347-Macrophages, pubmed-meshheading:16320347-Mice, pubmed-meshheading:16320347-Mutation, pubmed-meshheading:16320347-Polymorphism, Genetic, pubmed-meshheading:16320347-Promoter Regions, Genetic, pubmed-meshheading:16320347-Protein Binding, pubmed-meshheading:16320347-Proto-Oncogene Proteins, pubmed-meshheading:16320347-RNA, Messenger, pubmed-meshheading:16320347-Trans-Activators, pubmed-meshheading:16320347-Transcription, Genetic, pubmed-meshheading:16320347-Transcriptional Activation, pubmed-meshheading:16320347-Transfection
pubmed:year
2006
pubmed:articleTitle
Functional polymorphism in ALOX15 results in increased allele-specific transcription in macrophages through binding of the transcription factor SPI1.
pubmed:affiliation
Institute of Clinical Chemistry, Center for Integrative Human Physiology, University Hospital Zurich, Zurich, Switzerland.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't